Echinacea
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Echinacea
- DrugBank Accession Number
- DB14240
- Background
Not Available
- Type
- Biotech
- Groups
- Approved, Experimental
- Synonyms
- Echinacea angustifolia or echinacea pallida
- Echinacea, unspecified
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAbemaciclib The metabolism of Abemaciclib can be increased when combined with Echinacea. Acalabrutinib The metabolism of Acalabrutinib can be increased when combined with Echinacea. Acenocoumarol The metabolism of Acenocoumarol can be increased when combined with Echinacea. Albendazole The metabolism of Albendazole can be increased when combined with Echinacea. Alectinib The metabolism of Alectinib can be increased when combined with Echinacea. - Food Interactions
- No interactions found.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Echinacea Capsule 500 mg / cap Oral Nutraceutical Corporation Not applicable Not applicable Canada Echinacea - Liq Liquid 1 g / mL Oral Sisu Inc. 1995-12-31 2004-09-01 Canada Echinacea Capsules 400mg Capsule 400 mg / cap Oral Mczand Herbal Inc. 1995-12-31 1996-11-13 Canada Echinacea Plus Capsule 1000 mg / cap Oral Sisu Inc. 1998-11-10 2004-09-01 Canada Echinacea Tincture Tincture 200 mg / mL Oral Holista Health (Canada) Inc. 1997-07-14 2002-08-06 Canada - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Celestial Seasonings Herbal Comfort Lozenges Echinacea (50 mg / loz) + Eleuthero (25 mg / loz) Lozenge Oral Warner Lambert Canada Inc. Not applicable Not applicable Canada Echinacea With Goldenseal Root Echinacea (225 mg / cap) + Echinacea (225 mg / cap) + Goldenseal (50 mg / cap) Capsule Oral Au Naturel, Inc. Not applicable Not applicable Canada Echinacea With Goldenseal Root Echinacea (225 mg / cap) + Echinacea (225 mg / cap) + Goldenseal (50 mg / cap) Capsule Oral Au Naturel, Inc. Not applicable Not applicable Canada Ethical Herbals Sore Throat/cough/cold Defense Echinacea (125 mg / tab) + Goldenseal (12.5 mg / tab) Tablet Oral Ashbury Research Corporation Not applicable Not applicable Canada Herbon Sugar Free Wild Cherry Echinacea (100 mg/1) + Menthol (2 mg/1) Lozenge Oral Purity Life Division of SunOpta Co. 2009-09-30 2010-12-31 US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 4N9P6CC1DX
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample dataNot Available Completed Basic Science Upper Respiratory Tract Infection 2 somestatus stop reason just information to hide Not Available Completed Prevention Upper Respiratory Tract Infection 1 somestatus stop reason just information to hide Not Available Completed Treatment Ulcerative Colitis 1 somestatus stop reason just information to hide 4 Completed Not Available Healthy Volunteers (HV) 1 somestatus stop reason just information to hide 4 Completed Prevention Common Cold / Coronavirus Disease 2019 (COVID‑19) / Respiratory Tract Infections (RTI) 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Lozenge Oral Lozenge Oral 50 mg / loz Liquid Oral 1 g / mL Capsule Oral 400 mg / cap Liquid Oral 500 mg / mL Capsule Oral 1000 mg / cap Lozenge Oral 500 mg / loz Solution / drops Oral 307.5 mg / mL Tincture Oral 200 mg / mL Capsule Oral Capsule Oral 1000 mg Capsule Oral 325 mg / cap Tablet Oral 200 mg / tab Tablet Oral 166 mg / tab Tablet Oral Capsule Oral 500 mg / cap - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Enzymes
1. DetailsCytochrome P450 3A4
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- Actions
- Inducer
- General Function
- A cytochrome P450 monooxygenase involved in the metabolism of sterols, steroid hormones, retinoids and fatty acids (PubMed:10681376, PubMed:11093772, PubMed:11555828, PubMed:12865317, PubMed:14559847, PubMed:15373842, PubMed:15764715, PubMed:19965576, PubMed:20702771, PubMed:21490593, PubMed:21576599). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase). Catalyzes the hydroxylation of carbon-hydrogen bonds (PubMed:12865317, PubMed:14559847, PubMed:15373842, PubMed:15764715, PubMed:21490593, PubMed:21576599, PubMed:2732228). Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta-estradiol (E2), namely 2-hydroxy E1 and E2, as well as D-ring hydroxylated E1 and E2 at the C-16 position (PubMed:11555828, PubMed:12865317, PubMed:14559847). Plays a role in the metabolism of androgens, particularly in oxidative deactivation of testosterone (PubMed:15373842, PubMed:15764715, PubMed:22773874, PubMed:2732228). Metabolizes testosterone to less biologically active 2beta- and 6beta-hydroxytestosterones (PubMed:15373842, PubMed:15764715, PubMed:2732228). Contributes to the formation of hydroxycholesterols (oxysterols), particularly A-ring hydroxylated cholesterol at the C-4beta position, and side chain hydroxylated cholesterol at the C-25 position, likely contributing to cholesterol degradation and bile acid biosynthesis (PubMed:21576599). Catalyzes bisallylic hydroxylation of polyunsaturated fatty acids (PUFA) (PubMed:9435160). Catalyzes the epoxidation of double bonds of PUFA with a preference for the last double bond (PubMed:19965576). Metabolizes endocannabinoid arachidonoylethanolamide (anandamide) to 8,9-, 11,12-, and 14,15-epoxyeicosatrienoic acid ethanolamides (EpETrE-EAs), potentially modulating endocannabinoid system signaling (PubMed:20702771). Plays a role in the metabolism of retinoids. Displays high catalytic activity for oxidation of all-trans-retinol to all-trans-retinal, a rate-limiting step for the biosynthesis of all-trans-retinoic acid (atRA) (PubMed:10681376). Further metabolizes atRA toward 4-hydroxyretinoate and may play a role in hepatic atRA clearance (PubMed:11093772). Responsible for oxidative metabolism of xenobiotics. Acts as a 2-exo-monooxygenase for plant lipid 1,8-cineole (eucalyptol) (PubMed:11159812). Metabolizes the majority of the administered drugs. Catalyzes sulfoxidation of the anthelmintics albendazole and fenbendazole (PubMed:10759686). Hydroxylates antimalarial drug quinine (PubMed:8968357). Acts as a 1,4-cineole 2-exo-monooxygenase (PubMed:11695850). Also involved in vitamin D catabolism and calcium homeostasis. Catalyzes the inactivation of the active hormone calcitriol (1-alpha,25-dihydroxyvitamin D(3)) (PubMed:29461981)
- Specific Function
- 1,8-cineole 2-exo-monooxygenase activity
- Gene Name
- CYP3A4
- Uniprot ID
- P08684
- Uniprot Name
- Cytochrome P450 3A4
- Molecular Weight
- 57342.67 Da
References
- Awortwe C, Manda VK, Avonto C, Khan SI, Khan IA, Walker LA, Bouic PJ, Rosenkranz B: Echinacea purpurea up-regulates CYP1A2, CYP3A4 and MDR1 gene expression by activation of pregnane X receptor pathway. Xenobiotica. 2015 Mar;45(3):218-29. doi: 10.3109/00498254.2014.973930. Epub 2014 Nov 7. [Article]
- Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA, Desai M, Miller M, Hall SD: The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther. 2004 Jan;75(1):89-100. doi: 10.1016/j.clpt.2003.09.013. [Article]
Drug created at July 05, 2018 16:04 / Updated at October 21, 2024 08:50